MENU
KPTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Karyopharm Therapeutics (KPTI) Ownership - Who owns Karyopharm Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
85.49M
P/E Ratio
N/A
Total Cash
133.53M
Projected Growth
N/A
Total Debt
194.26M
Revenue
148.44M
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash/Share
1.06
Total Debt/Equity
N/A
Revenue/Share
1.20 USD as % of share price
Fundamentals
KPTI
Capitalization
85.5M
P/E Ratio
N/A
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash
134M
Total Cash/Share
1.06
Total Debt
194M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.20%
Revenue
148M
ROE
N/A
Book Value
-159.65M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.74
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
3.00
Current Revenue Per Employee
119332.30
Dividends Per Share - Security
N/A
EBITDA
-54.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.65
Revenue To Assets
-38.08
Shares Held By Institutions
77.6M
Shares Outstanding - Current
126M
Total Liabilities
349M
Total Volume MTD
N/A
Value
1
Gain YTD
-22.936
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com